Metamizolnatrij Hidrat Kalceks

Metamizole Sodium Monohydrate, the active ingredient in Metamizolnatrij Hidrat Kalceks, is a pyrazolone non‑opioid analgesic presented as a sterile solution for intramuscular and intravenous use. It provides analgesic and antipyretic effects for patients with acute moderate to severe pain, postoperative pain, colic, visceral pain, and fever.

GNH USA supplies Metamizolnatrij Hidrat Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metamizole Sodium Monohydrate is used for pain and fever management across several clinical situations.

Acute moderate to severe pain: rapid relief of intense nociceptive pain. Post‑operative pain: reduction of discomfort after surgical procedures. Colic and visceral pain: alleviation of spasm‑related abdominal pain. Fever: effective lowering of elevated body temperature.

Metamizole Sodium Monohydrate may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Dizziness: transient light‑headedness. - Injection site pain: local discomfort after IM/IV administration. - Transient hypotension: temporary drop in blood pressure. - Mild leukopenia: temporary reduction in white blood cells. - Headache: occasional mild headache.

Serious or Rare Side Effects: - Agranulocytosis: severe depletion of neutrophils, potentially life‑threatening. - Anaphylaxis: acute allergic reaction with respiratory compromise. - Stevens‑Johnson syndrome: severe skin and mucous membrane disorder. - Blood dyscrasias: rare cases of thrombocytopenia or hemolytic anemia.

When using Metamizole Sodium Monohydrate, clinicians should consider several safety measures.

Renal impairment: monitor kidney function and adjust use as needed. Hepatic disease: use with caution in patients with liver dysfunction. History of blood disorders: avoid in patients with prior agranulocytosis. Concomitant anticoagulants: increased bleeding risk, monitor coagulation parameters. Pregnancy and lactation: safety not established; avoid unless essential. Store at ambient temperature: keep in original container, protect from moisture and light.

Metamizole Sodium Monohydrate can interact with other medicines; awareness of the level of interaction is important.

Major Interactions (Avoid): - Cytotoxic chemotherapy agents: additive bone‑marrow suppression. - Sulfonamide antibiotics: increased risk of agranulocytosis. - Immunosuppressants: heightened infection risk.

Moderate Interactions (Monitor Closely): - Warfarin: may potentiate anticoagulant effect, monitor INR. - ACE inhibitors: possible additive hypotensive effect. - Diuretics: monitor electrolyte balance.